There is, what looks like, an excellent meeting in London, full details are on the SMR website. I hope I feel better by then.
SMR Award Meeting: Recent Disclosures of Clinical Candidates 10th December 2009 National Heart & Lung Institute, Kensington, London | |
| Programme: | |
| 09.30 | Registration and coffee |
| 10.00 | SMR Award lecture: The Discovery and development of Januvia™, Dr. Ann Weber, Merck (Introduction by - Rob Williams, Cancer Research UK) |
| Session 1 - Chair: Mark Searcy, University of East Anglia | |
| 11.00 | Chris Murray, Astex From fragment to clinic - the discovery of the hsp90 inhibitor, AT13387. |
| 11.45 | George Muller, Celgene The discovery of apremilast. |
| 12.30 | Lunch (Including SMR AGM 13.10-13.30) |
Session 2 - Chair: Diane Coe, GSK | |
| 13.30 | David Fox, Pfizer The discovery of a second generation long-acting PDE5 inhibitor. |
| 14.15 | Simon Hodgson, GSK The discovery of a dual H1/H3 antagonist for allergic rhinitis. |
| 15.00 | Tea |
| Session 3 - Chair: David Fox, Pfizer | |
| 15.30 | Karl Gibson, Pfizer The discovery of a progesterone receptor antagonist for endometriosis. |
| 16.15 | Mairi Gibson, GSK Second generation EP1 antagonists for the treatment of pain. |
| 17.00 | Close |
Comments